A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/10/2011	WO2011140324A1 Indoles
11/10/2011	WO2011140315A2 Method of reducing proteins misfolding and/or aggregation
11/10/2011	WO2011140310A2 Povidone-iodine topical composition
11/10/2011	WO2011140296A1 Triazoles as inhibitors of fatty acid synthase
11/10/2011	WO2011140236A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
11/10/2011	WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	WO2011140228A1 Nuclear receptor binding agents
11/10/2011	WO2011140198A2 Compounds and methods of treating brain disorders
11/10/2011	WO2011140194A1 Ophthalmic composition
11/10/2011	WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	WO2011140183A1 Process for synthesizing oxidized lactam compounds
11/10/2011	WO2011140173A1 Detection and treatment of fibrosis
11/10/2011	WO2011140164A1 Aza-indole derivatives useful as modulators of faah
11/10/2011	WO2011140161A1 Benzofuranyl analogues as gpr119 modulators
11/10/2011	WO2011140160A1 Bicyclic heteroaryl compounds as gpr119 modulators
11/10/2011	WO2011140078A1 Synthetic triterpenoid derivatives
11/10/2011	WO2011140066A1 Novel piperidine-flavan alkaloid compounds derived from african herb tea kinkeliba as anti-diabetic agents
11/10/2011	WO2011140009A1 Methods of using semi-synthetic glycopeptides as antibacterial agents
11/10/2011	WO2011139983A1 Novel methods of use of tetrahydroberberine (thb)
11/10/2011	WO2011139951A1 Modulators of fatty acid amide hydrolase
11/10/2011	WO2011139899A2 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
11/10/2011	WO2011139897A2 Reduction of alpha-tocopherol quinone
11/10/2011	WO2011139891A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
11/10/2011	WO2011139886A2 Preparation of febuxostat
11/10/2011	WO2011139881A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
11/10/2011	WO2011139868A2 Method for treating esophageal cancer
11/10/2011	WO2011139867A2 Method of treating brain cancer
11/10/2011	WO2011139832A2 Method for treating mycobacterial infections
11/10/2011	WO2011139811A1 Nicotine-containing pharmaceutical compositions
11/10/2011	WO2011139794A2 A composition for skin sanitization and protection and method of its use
11/10/2011	WO2011139791A2 Bisphosphonamidate prodrugs and uses thereof
11/10/2011	WO2011139765A2 Compounds that modulate intracellular calcium
11/10/2011	WO2011139763A1 Methods and compositions for inducing satiety
11/10/2011	WO2011139752A2 Preparation of polypeptides and salts thereof
11/10/2011	WO2011139709A2 Methods of treating retroviral infections and related dosage regimes
11/10/2011	WO2011139637A1 Small-molecule modulators of hiv-1 capsid stability and methods thereof
11/10/2011	WO2011139636A1 Small molecule inhibitors of functions of the hiv-1 matrix protein
11/10/2011	WO2011139558A1 Formulations and methods of treatment of skin conditions
11/10/2011	WO2011139525A1 Stereoisomer of naloxone and potential therapeutic action of opioid drugs to reverse clinical tolerance to these agents
11/10/2011	WO2011139513A1 Compounds for the treatment of hepatitis c
11/10/2011	WO2011139489A2 Compounds that modulate intracellular calcium
11/10/2011	WO2011139420A2 Propynylaminoindan transdermal compositions
11/10/2011	WO2011139414A2 Dexlansoprazole polymorphic forms
11/10/2011	WO2011139387A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
11/10/2011	WO2011139379A2 A method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities
11/10/2011	WO2011139378A1 Compounds and methods for treatment of systemic lupus erythematosus
11/10/2011	WO2011139373A1 Compositions of small molecule therapeutics
11/10/2011	WO2011139348A2 Uses of phospholipid conjugates of synthetic tlr7 agonists
11/10/2011	WO2011139343A2 Amino acid linked peg-lipid conjugates
11/10/2011	WO2011139295A1 Small molecule inhibitors of protein kinases
11/10/2011	WO2011139273A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors
11/10/2011	WO2011139271A1 Immediate release formulations and dosage forms of gamma-hydroxybutyrate
11/10/2011	WO2011139251A1 Pharmaceutical compositions comprising cefditoren pivoxil
11/10/2011	WO2011139246A1 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases
11/10/2011	WO2011139237A1 Composition for the treatment of helicobacter pylori (h. pylori) infectious
11/10/2011	WO2011139218A1 Nucleic acid delivery vehicle uses thereof
11/10/2011	WO2011139172A1 Diterpene compounds with antineoplastic activities and pharmaceutical compositions comprising same
11/10/2011	WO2011139168A1 Immunostimulatory compositions and methods of use thereof
11/10/2011	WO2011139107A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
11/10/2011	WO2011139079A2 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
11/10/2011	WO2011139044A2 Controlled-release pharmaceutical composition including tamsulosin or the pharmaceutically acceptable salts thereof, and oral preparation including same
11/10/2011	WO2011139010A1 Composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient
11/10/2011	WO2011138977A1 Method of preventing or treating body weight-related disorders by employing vaspin
11/10/2011	WO2011138973A1 Vitamin-containing nutrition infusion for administration through peripheral vein
11/10/2011	WO2011138956A1 Novel prenylarene compound and use thereof
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138801A1 Novel ophthalmic compositions
11/10/2011	WO2011138772A1 A pharmaceutical composition comprising aspirin and bisoprolol
11/10/2011	WO2011138678A2 Compositions, gels and foams with rheology modulators and uses thereof
11/10/2011	WO2011138666A1 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
11/10/2011	WO2011138665A1 Novel immunomodulator and anti inflammatory compounds
11/10/2011	WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011	WO2011138653A1 Combination of an nsaid and an amino acid
11/10/2011	WO2011138565A1 Pharmaceutical combination containing lipoic acid, hydroxycitric acid and a somatostatin as active ingredients
11/10/2011	WO2011138512A1 Sulphated hyaluronic acid in combination with g-csf for use in mobilising blood stem cells
11/10/2011	WO2011138460A1 Progesterone receptor antagonists and uses thereof
11/10/2011	WO2011138427A2 Pyridazinones as gpr119 agonists
11/10/2011	WO2011138421A1 Combination therapy
11/10/2011	WO2011138409A1 Combretastatin analogs for use in the treatment of cancer
11/10/2011	WO2011138398A1 Dosage regimen of diaryl sulfide derivatives
11/10/2011	WO2011138393A1 Treatment of autoimmune diseases
11/10/2011	WO2011138380A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/10/2011	WO2011138364A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
11/10/2011	WO2011138328A2 Use of inhibitory molecules for the treatment of pulmonary hypertension
11/10/2011	WO2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
11/10/2011	WO2011138293A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
11/10/2011	WO2011138266A1 Indolizine and imidazopyridine derivatives as orexin receptor antagonists
11/10/2011	WO2011138265A2 Indole and indazole derivatives as orexin receptor antagonists
11/10/2011	WO2011138262A1 Topical pharmaceutical composition comprising heparin
11/10/2011	WO2011138228A1 Aqueous composition for ophthalmic or dermal use
11/10/2011	WO2011138197A2 Novel low concentration meloxicam tablets
11/10/2011	WO2011138155A1 Chitosan composition
11/10/2011	WO2011138142A1 Compositions and use of sulfasalazine
11/10/2011	WO2011138037A2 Solid tapentadol in non-crystalline form
11/10/2011	WO2011137925A1 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
11/10/2011	WO2011137894A1 Melting tablet comprising a triptane or atypical neuroleptic
11/10/2011	WO2011137877A2 A pharmaceutical composition containing solifenacin and a method of its manufacture
11/10/2011	WO2011137759A1 Novel ecdysterone synthesis derivative, preparation method and use thereof
11/10/2011	WO2011137758A1 Novel ketolide derivatives, preparation methods and pharmaceutical compositions thereof
11/10/2011	WO2011137734A1 Pharmaceutical composition and method for treating hypertension

1 ... 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 ... 7860